...
首页> 外文期刊>Scandinavian journal of urology >Measurement of serum isoform [-2]proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2-10ng/ml
【24h】

Measurement of serum isoform [-2]proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2-10ng/ml

机译:血清同种型的测量[-2] ProCSA衍生物显示出磁共振成像在患有总前列腺特异性抗原水平2-10ng / ml的患者的前列腺癌中的磁共振成像的卓越精度

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: More accurate diagnostic procedures for prostate cancer are needed to avoid unnecessary biopsy due to the low specificity of prostate-specific antigen (PSA). Recent studies showed that the percentage of serum isoform [-2]proPSA (p2PSA) to free PSA (%p2PSA), the Prostate Health Index (PHI) and magnetic resonance imaging (MRI) were more accurate than PSA. The aim of this study was to test the accuracy of %p2PSA, PHI and MRI in discriminating patients with and without prostate cancer.
机译:目的:需要更准确地为前列腺癌进行诊断程序,以避免由于前列腺特异性抗原(PSA)的低特异性导致不必要的活组织检查。 最近的研究表明,对游离PSA(%P2PSA),前列腺健康指数(PHI)和磁共振成像(MRI)比PSA更加精确的血清异紫色[-2] PROPSA(P2PSA)的百分比更加精确。 本研究的目的是在鉴别患者和不含前列腺癌的患者中测试%P2PSA,PHI和MRI的准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号